Department of Biochemistry, Universities of Giessen and Marburg Lung Center, Giessen, Germany.
Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hanover, Germany.
Biochim Biophys Acta Gen Subj. 2017 Aug;1861(8):2088-2098. doi: 10.1016/j.bbagen.2017.05.023. Epub 2017 May 25.
Factor XII (FXII) is a serine protease that is involved in activation of the intrinsic blood coagulation, the kallikrein-kinin system and the complement cascade. Although the binding of FXII to the cell surface has been demonstrated, the consequence of this event for proteolytic processing of membrane-anchored proteins has never been described.
The effect of FXII on the proteolytic processing of the low-density lipoprotein receptor-related protein 1 (LRP1) ectodomain was tested in human primary lung fibroblasts (hLF), alveolar macrophages (hAM) and in human precision cut lung slices (hPCLS). The identity of generated LRP1 fragments was confirmed by MALDI-TOF-MS. Activity of FXII and gelatinases was measured by S-2302 hydrolysis and zymography, respectively.
Here, we demonstrate a new function of FXII, namely its ability to process LRP1 extracellular domain. Incubation of hLF, hAM, or hPCLS with FXII resulted in the accumulation of LRP1 ectodomain fragments in conditioned media. This effect was independent of metalloproteases and required FXII proteolytic activity. Binding of FXII to hLF surface induced its conversion to FXIIa and protected FXIIa against inactivation by a broad spectrum of serine protease inhibitors. Preincubation of hLF with collagenase I impaired FXII activation and, in consequence, LRP1 cleavage. FXII-triggered LRP1 processing was associated with the accumulation of gelatinases (MMP-2 and MMP-9) in conditioned media.
FXII controls LRP1 levels and function at the plasma membrane by modulating processing of its ectodomain.
FXII-dependent proteolytic processing of LRP1 may exacerbate extracellular proteolysis and thus promote pathological tissue remodeling.
凝血因子 XII(FXII)是一种丝氨酸蛋白酶,参与内源性血液凝固、激肽释放酶-激肽系统和补体级联的激活。虽然已经证明 FXII 与细胞表面结合,但该事件对膜锚定蛋白的蛋白水解加工的后果从未被描述过。
在人原代肺成纤维细胞(hLF)、肺泡巨噬细胞(hAM)和人精密切割肺切片(hPCLS)中测试 FXII 对低密度脂蛋白受体相关蛋白 1(LRP1)胞外域蛋白水解加工的影响。通过 MALDI-TOF-MS 确认生成的 LRP1 片段的身份。通过 S-2302 水解和胶凝酶谱法分别测量 FXII 和明胶酶的活性。
在这里,我们证明了 FXII 的一个新功能,即其加工 LRP1 细胞外结构域的能力。将 hLF、hAM 或 hPCLS 与 FXII 孵育会导致 LRP1 胞外结构域片段在条件培养基中积累。这种作用不依赖于金属蛋白酶,需要 FXII 的蛋白水解活性。FXII 与 hLF 表面结合诱导其转化为 FXIIa,并防止 FXIIa 被广谱丝氨酸蛋白酶抑制剂失活。hLF 与胶原酶 I 预孵育会损害 FXII 的激活,从而导致 LRP1 切割。FXII 触发的 LRP1 加工与条件培养基中明胶酶(MMP-2 和 MMP-9)的积累有关。
FXII 通过调节其胞外结构域的加工来控制质膜上的 LRP1 水平和功能。
FXII 依赖性的 LRP1 蛋白水解加工可能会加剧细胞外蛋白水解,从而促进病理性组织重塑。